Images used in the following scientific publications:
- Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation (Creative Commons Attribution 4.0 International License)
- Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis (License CC-BY-ND4)
- IL‐11 in cardiac and renal fibrosis: Late to the party but a central player. (Creative Commons Attribution‐NonCommercial‐NoDerivs License)
- Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation (Creative Commons Attribution 4.0 International License)
- Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis (License CC-BY-ND4)
- IL‐11 in cardiac and renal fibrosis: Late to the party but a central player. (Creative Commons Attribution‐NonCommercial‐NoDerivs License)
Images used in the following scientific publications:
- Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary Fibroblasts
- The pro-regenerative effects of hyperIL6 in drug-induced liver injury are unexpectedly due to competitive inhibition of IL11 signaling
- Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary Fibroblasts
- The pro-regenerative effects of hyperIL6 in drug-induced liver injury are unexpectedly due to competitive inhibition of IL11 signaling
Images used in the following scientific publications:
- Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH (above)
- A neutralizing IL11 antibody improves renal function and increases lifespan in a mouse model of Alport syndrome (below)
- Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH (above)
- A neutralizing IL11 antibody improves renal function and increases lifespan in a mouse model of Alport syndrome (below)
